Ipamorelin Clinical Trials: Registered Studies and Status
As of November 2, 2026, ClinicalTrials.gov lists 2 registered studies matching Ipamorelin or its known aliases as an intervention.
Summary
- Registered studies
- 2
- Most advanced phase
- Phase 2
- Recruiting or not yet recruiting
- 0
- Most recent start
- 2011-04
- Most frequent lead sponsor
- Helsinn Therapeutics (U.S.), Inc (2)
- Most common status
- Completed
Source: ClinicalTrials.gov, retrieved . Registry searches by name may miss studies that use other identifiers.
Registered studies
| NCT ID | Title | Phase | Status | Enrollment | Start | Lead sponsor |
|---|---|---|---|---|---|---|
| NCT01280344 | Safety and Efficacy of Ipamorelin Compared to Placebo for the Recovery of Gastrointestinal Function | Phase 2 | Completed | 320 | 2011-04 | Helsinn Therapeutics (U.S.), Inc |
| NCT00672074 | Safety and Efficacy of Ipamorelin for Management of Post-Operative Ileus | Phase 2 | Completed | 117 | 2008-04 | Helsinn Therapeutics (U.S.), Inc |
Method and limitations
- Data source: ClinicalTrials.gov API v2, intervention search.
- Query used:
Ipamorelin OR "NNC 26-0161" - Retrieved: November 2, 2026. Refreshed weekly; changes are reviewed before publication.
- Studies registered only under other names, sponsor codes, or in other registries may be missing.
- A match on name does not mean the study tested this peptide alone; some studies include it as a comparator or combination.
- Status values are reported by sponsors and may be out of date.